Table 3.
Biomarker | No of interventions | Risk of bias1 | Inconsistency (heterogeneity)2 | Indirectness3 | Imprecision4 | Publication bias 5 | Effect size6 | Certainty of evidence |
---|---|---|---|---|---|---|---|---|
25(OH)D | 15 | Very serious | Very serious | Serious | Not serious | Serious | + 2 | Low |
CB 25(OH)D | 3 | Very serious | Very serious | Serious | Very serious | Very serious | + 2 | Very low |
hs-CRP | 11 | Very serious | Very serious | Serious | Serious | Not serious | 0 | Very low |
TAC | 9 | Very serious | Very serious | Serious | Not serious | Serious | + 2 | Low |
MDA | 6 | Very serious | Serious | Serious | Not serious | Serious | 0 | Low |
GSH | 9 | Very serious | Very serious | Serious | Not serious | Serious | + 2 | Low |
1 risk of bias: no problem = not serious (0); problem with 1 element = severe (-1); problem with 2 or more elements = very severe (-2)
2 inconsistency: I2 < 50% = not serious (0), 50–75% = serious (-1), > 75% = very serious (-2)
3 indirectness or variation in participants, intervention, outcome variables: no problem = low; problem with 1 element = serious (-1); problem with 2 or more elements = very serious (-2)
4 imprecision: > 5 studies = not serious (0); 4 to 5 studies = serious (-1); 3 or less studies = very serious (-2)
5 publication bias: no publication bias = not serious, publication bias proved by only one method of assessment = serious, publication proved by more than one method of assessment besides a considerable difference between the combined and pure measurement = very serious
6 scoring: lower than 0.5 = 0, between 0.5 and 0.79 = + 1, 0.8 or higher = + 2
Abbreviations: 25(OH)D 25-hydroxyvitamin D3, CB Cord Blood, hs-CRP High-sensitivity C-reactive protein, K Number of studies, TAC Total antioxidant capacity, MDA Malondialdehyde, GSH Glutathione